Avai Bio, Inc.
AVAI· OTC
AVAIAvai Bio, Inc.
Filed Feb 12, 2026 · 10-Q · 43 days after period end · 0001740797-26-000009
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$553.73K | -$452.30K | -$1.01M | -$417.16K |
| EPS Diluted | — | — | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Feb 12, 2026 · 43 d after period end
